| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |